Invention Grant
- Patent Title: Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
-
Application No.: US15800921Application Date: 2017-11-01
-
Publication No.: US10420827B2Publication Date: 2019-09-24
- Inventor: Camille Locht , Bernard Mahon , Heather Kavanaugh
- Applicant: Institut National de la Santé et de la Recherche Médicale (INSERM) , Institut Pasteur de Lille , National University of Ireland Maynooth
- Applicant Address: FR Paris FR Lille IE Maynooth
- Assignee: Institut National de la Santé et de la Recherche Médicale (INSERM),Institut Pasteur de Lille,National University of Ireland Maynooth
- Current Assignee: Institut National de la Santé et de la Recherche Médicale (INSERM),Institut Pasteur de Lille,National University of Ireland Maynooth
- Current Assignee Address: FR Paris FR Lille IE Maynooth
- Agent Stanley A. Kim
- Priority: EP09305371 20090428
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K39/00
Abstract:
The present invention relates to a life attenuated Bordetella pertussis vaccine which is deficient for tracheal cytotoxin (TCT), pertussis toxin (PTX), and dermonecrotic toxin (DNT) for prophylaxis or treatment of an allergen-driven airway pathology.
Public/Granted literature
- US20180085450A1 Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology Public/Granted day:2018-03-29
Information query
